Resmonics

Founded: 2020 • Age: 6 yrs
AI-based system for monitoring respiratory diseases is provided.
Annual revenue - Latest available
Total funding $163,152 3 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 2 Services tracked
Competitors 9 Brand Intelligence

About Resmonics

Resmonics is a company founded in 2020 by Iris Shih and Peter Tinschert. Resmonics has raised $163.15 thousand across 3 funding rounds from investors including Venture Kick and CSS. Resmonics offers products and services including Resmonics AI and ResGuard Med. Resmonics operates in a competitive market with competitors including VitalFlo, Inofab Health, My mHealth, PerSapien and AsthmaMD, among others.

  • Founders Iris Shih, Peter Tinschert
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Resmonics Ag
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $163.15 K (USD)

    in 3 rounds

  • Latest Funding Round
    $163.15 K (USD), Seed

    Jun 23, 2021

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Resmonics

Resmonics offers a comprehensive portfolio of products and services, including Resmonics AI and ResGuard Med.

Product name locked
Category locked
Primary

AI system for real-time disinfection monitoring and infection prediction.

Product name locked
Category locked
Locked

Software for detecting and analyzing respiratory symptoms in healthcare.

Funding Insights of Resmonics

Resmonics has successfully raised a total of $163.15K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $163.15 thousand completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Resmonics

Resmonics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Venture Kick and CSS.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
University backed startup accelerator
Locked Locked Locked
CSS is recognized as a health insurance provider in Switzerland.
Locked Locked Locked
Premium access

Investor details for Resmonics

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Resmonics

Investments
Premium access

Investment portfolio details for Resmonics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Resmonics

Premium access

Detailed financials for Resmonics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Resmonics Comparisons

Resmonics Primary company
Description
AI-based system for monitoring respiratory diseases is provi...
Location
-
Founded Year
2020
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Resmonics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Resmonics

Resmonics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as VitalFlo, Inofab Health, My mHealth, PerSapien and AsthmaMD, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
App for managing asthma through clinical insights
Locked Locked Locked
Spirometer applications for respiratory health monitoring are developed.
Locked Locked Locked
Chronic conditions are managed via an online patient platform.
Locked Locked Locked
Respiratory health is supported by nasal purifier and AQI-tracking app.
Locked Locked Locked
AsthmaMD is focused on asthma management through mobile technology.
Premium access

Detailed competitors of Resmonics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Resmonics

Premium access

Complete news archive for Resmonics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Resmonics

Resmonics was founded in 2020.

Peter Tinschert is the current CEO of Resmonics. They have also founded this company.

Resmonics is a funded company, having raised a total of $163.15K across 3 funding rounds to date.

Resmonics was founded in 2020 as a provider of an AI-driven platform for respiratory disease monitoring. Deep learning technology is utilized on clinically validated biomarkers to develop an asthma warning system. Symptoms are monitored automatically and passively overnight via a smartphone app. Notifications are delivered to patients during medical emergencies. Operations focus on health technology within the digital health sector.

Resmonics's top competitors include VitalFlo, My mHealth and Inofab Health.

Resmonics offers Resmonics AI and ResGuard Med.

Resmonics has 2 investors. Key investors include Venture Kick, and CSS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available